Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients--relationship with plasma insulin.

Juhan-Vague I, Roul C, Alessi MC, Ardissone JP, Heim M, Vague P.

Thromb Haemost. 1989 Jun 30;61(3):370-3.

PMID:
2678583
6.

A significant relationship between plasminogen activator inhibitor type-1 and lipoprotein(a) in non-insulin-dependent diabetes mellitus without complications.

Testa R, Bonfigli AR, Pieri C, Marra M, Sirolla C, Manfrini S, Testa I.

Int J Clin Lab Res. 1998;28(3):187-91.

PMID:
9801931
7.

Plasminogen activator inhibitor-1 in nonobese subjects with non-insulin-dependent diabetes mellitus.

Ito Y, Okeda T, Sato Y, Ito M, Sakata T.

Proc Soc Exp Biol Med. 1996 Mar;211(3):287-91.

PMID:
8633110
8.

The effect of insulin treatment on the balance between tissue plasminogen activator and plasminogen activator inhibitor-1 in type 2 diabetic patients.

Vukovich T, Proidl S, Knöbl P, Teufelsbauer H, Schnack C, Schernthaner G.

Thromb Haemost. 1992 Sep 7;68(3):253-6.

PMID:
1440487
10.

Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response.

Juhan-Vague I, Alessi MC, Joly P, Thirion X, Vague P, Declerck PJ, Serradimigni A, Collen D.

Arteriosclerosis. 1989 May-Jun;9(3):362-7.

11.

Different metabolic correlations of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 in non-obese type 2 diabetic patients.

Kitagawa N, Yano Y, Gabazza EC, Bruno NE, Araki R, Matsumoto K, Katsuki A, Hori Y, Nakatani K, Taguchi O, Sumida Y, Suzuki K, Adachi Y.

Diabetes Res Clin Pract. 2006 Aug;73(2):150-7. Epub 2006 Feb 3.

PMID:
16458385
12.

Plasma t-PA and PAI-1 antigen concentrations in non-insulin dependent diabetic patients: implication for diabetic retinopathy.

Cho YW, Yang DH, Oh DY, Baick SH, Kim SK, Kim SJ, Hong SY.

Diabetes Res Clin Pract. 1994 Jan;22(2-3):123-8.

PMID:
8200293
13.

Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.

Juhan-Vague I, Vague P, Alessi MC, Badier C, Valadier J, Aillaud MF, Atlan C.

Diabete Metab. 1987 Jul;13(3 Pt 2):331-6.

PMID:
3115843
14.

Hypofibrinolysis associated with vasculopathy in non insulin dependent diabetes mellitus.

García Frade LJ, de la Calle H, Torrado MC, Lara JI, Cuellar L, García Avello A.

Thromb Res. 1990 Jul 1;59(1):51-9.

PMID:
2119076
15.
16.

Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women.

De Mitrio V, De Pergola G, Vettor R, Marino R, Sciaraffia M, Pagano C, Scaraggi FA, Di Lorenzo L, Giorgino R.

Metabolism. 1999 Aug;48(8):960-4.

PMID:
10459558
18.

Increased plasminogen activator inhibitor activity and diabetes predict subsequent coronary events in patients with angina pectoris.

Takazoe K, Ogawa H, Yasue H, Sakamoto T, Soejima H, Miyao Y, Kawano H, Moriyama Y, Misumi K, Suefuji H, Kugiyama K, Yoshimura M.

Ann Med. 2001 Apr;33(3):206-12.

PMID:
11370775
19.
20.

Beneficial effect of a moderately energy-restricted diet on fibrinolytic factors in non-obese men.

Velthuis-te Wierik EJ, Meijer P, Kluft C, van den Berg H.

Metabolism. 1995 Dec;44(12):1548-52.

PMID:
8786722

Supplemental Content

Support Center